Literature DB >> 7188698

Immunogenicity of boiled compared with formalized leptospiral vaccines in rabbits, hamsters and humans.

B Adler, S Faine.   

Abstract

Leptospires (Leptospira interrogans serovar pomona) grown in chemically defined medium were immunogenic when given intradermally in humans if the leptospires were killed with formalin but not if they were boiled. Boiled leptospires were immunogenic for rabbits and hamsters and protected hamsters from challenge infection. On the other hand, boiled leptospires of the biflexa complex, serovar patoc, did retain some immunogenicity in humans, but the antisera did not protect hamsters against challenge with serovar pomona.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7188698      PMCID: PMC2133829          DOI: 10.1017/s0022172400026450

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  18 in total

1.  A new leptospiral vaccine for use in man. II. Clinical and serologic evaluation of a field trial with volunteers.

Authors:  M Torten; E Shenberg; C B Gerichter; P Neuman; M A Klingberg
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

Review 2.  Antibody heterogeneity and serological reactions.

Authors:  R M Pike
Journal:  Bacteriol Rev       Date:  1967-06

3.  Antibody response of cattle to Leptospira pomona: response as measured by hemagglutination, microscopic agglutination, and hamster protection tests.

Authors:  S K Negi; W L Myers; D Segre
Journal:  Am J Vet Res       Date:  1971-12       Impact factor: 1.156

4.  A new leptospiral vaccine for use in man. I. Development of a vaccine from Leptospira grown on a chemically defined medium.

Authors:  E Shenberg; M Torten
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  Molecular characteristics of antibody detected by the microscopic agglutination test in serum of guinea pigs with leptospirosis.

Authors:  R P Crawford
Journal:  Am J Vet Res       Date:  1972-07       Impact factor: 1.156

Review 6.  Leptospirosis. II. Serology.

Authors:  L H Turner
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

7.  Chemical, serological and biological properties of a serotype-specific polysaccharide antigen in Leptospira.

Authors:  S Faine; B Adler; A Palit
Journal:  Aust J Exp Biol Med Sci       Date:  1974-04

8.  Growth of pathogenic Leptospira in chemically defined media.

Authors:  E Shenberg
Journal:  J Bacteriol       Date:  1967-05       Impact factor: 3.490

9.  Growth requirements of pathogenic Leptospira.

Authors:  J L Staneck; R C Henneberry; C D Cox
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

10.  Antileptospiral agglutinins produced in rabbits.

Authors:  S Graves; S Faine
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  4 in total

1.  Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant.

Authors:  Amporn Srikram; Kunkun Zhang; Thanatchaporn Bartpho; Miranda Lo; David E Hoke; Rasana W Sermswan; Ben Adler; Gerald L Murray
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

2.  The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.

Authors:  Everton F Silva; Marco A Medeiros; Alan J A McBride; Jim Matsunaga; Gabriela S Esteves; João G R Ramos; Cleiton S Santos; Júlio Croda; Akira Homma; Odir A Dellagostin; David A Haake; Mitermayer G Reis; Albert I Ko
Journal:  Vaccine       Date:  2007-06-14       Impact factor: 3.641

3.  Leptospirosis vaccines.

Authors:  Zhijun Wang; Li Jin; Alicja Wegrzyn
Journal:  Microb Cell Fact       Date:  2007-12-11       Impact factor: 5.328

4.  Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection.

Authors:  Veerapandian Raja; Sankaran Sobana; Charles Solomon Akino Mercy; Bianca Cotto; Durlav Prasad Bora; Kalimuthusamy Natarajaseenivasan
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.